Patents by Inventor Lynn Bristol

Lynn Bristol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aberrant glutamate transporters and methods of use
    Patent number: 7060457
    Abstract: In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: June 13, 2006
    Assignee: Johns Hopkins University
    Inventors: Jeffrey D. Rothstein, Chieng-Liang Glenn Lin, Lynn A. Bristol
  • Methods for detecting neurological disorders
    Publication number: 20060040315
    Abstract: In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
    Type: Application
    Filed: October 28, 2005
    Publication date: February 23, 2006
    Applicant: Johns Hopkins University
    Inventors: Jeffrey Rothstein, Chieng-Liang Lin, Lynn Bristol
  • ABERRANT GLUTAMATE TRANSPORTERS AND METHODS OF USE
    Publication number: 20030060617
    Abstract: In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
    Type: Application
    Filed: March 18, 1998
    Publication date: March 27, 2003
    Inventors: CHIENG-LIANG GLENN LIN, LYNN A. BRISTOL, JEFFERY D. ROTHSTEIN